Central role for endothelial human deneddylase-1/SENP8 in fine-tuning the vascular inflammatory response

Journal of Immunology

Volumn 190, Issue 1, 2013, Pages 392-400

  Ehrentraut, Stefan F ^a   Kominsky, Douglas J ^a   Glover, Louise E ^a   Campbell, Eric L ^a   Kelly, Caleb J ^a   Bowers, Brittelle E ^a   Bayless, Amanda J ^a   Colgan, Sean P ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

[4 [4 [(2,3 DIHYDRO 1H INDEN 1 YL)AMINO] 7H PYRROLO[2,3 D]PYRIMIDIN 7 YL] 2 HYDROXYCYCLOPENTYLMETHYL] SULFAMATE; CULLIN; CYTOKINE; HYPOXIA INDUCIBLE FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; LIGASE; LIPOPOLYSACCHARIDE; PROTEIN; SENP8 PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; DRUG TARGETING; ENDOTHELIUM; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NEDDYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN STABILITY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CELLS, CULTURED; CULLIN PROTEINS; ENDOPEPTIDASES; ENDOTHELIUM, VASCULAR; ENZYME PRECURSORS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION MEDIATORS; MICROCIRCULATION; UBIQUITINS;

EID: 84871837594     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202041     Document Type: Article

References (54)

1. Angus, D. C., W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky. 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29: 1303-1310. (Pubitemid 32641789)
2. Martin, G. S., D. M. Mannino, S. Eaton, and M. Moss. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348: 1546-1554. (Pubitemid 36437931)
3. Paulus, P., C. Jennewein, and K. Zacharowski. 2011. Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis? Biomarkers 16(Suppl. 1): S11-S21.
4. Shapiro, N. I., P. Schuetz, K. Yano, M. Sorasaki, S. M. Parikh, A. E. Jones, S. Trzeciak, L. Ngo, and W. C. Aird. 2010. The association of endothelial cell signaling, severity of illness, and organ dysfunction in sepsis. Crit. Care 14: R182.
5. Baker, R. G., M. S. Hayden, and S. Ghosh. 2011. NF-κB, inflammation, and metabolic disease. Cell Metab. 13: 11-22.
6. Hayden, M. S., and S. Ghosh. 2008. Shared principles in NF-κB signaling. Cell 132: 344-362.
7. Barnes, P. J., and M. Karin. 1997. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336: 1066-1071. (Pubitemid 27163860)
8. Walmsley, S. R., C. Print, N. Farahi, C. Peyssonnaux, R. S. Johnson, T. Cramer, A. Sobolewski, A. M. Condliffe, A. S. Cowburn, N. Johnson, and E. R. Chilvers. 2005. Hypoxia-induced neutrophil survival is mediated by HIF-1α-dependent NF-κB activity. J. Exp. Med. 201: 105-115. (Pubitemid 40130088)
9. Belaiba, R. S., S. Bonello, C. Zähringer, S. Schmidt, J. Hess, T. Kietzmann, and A. Görlach. 2007. Hypoxia up-regulates hypoxia-inducible factor-1α transcription by involving phosphatidylinositol 3-kinase and nuclear factor κB in pulmonary artery smooth muscle cells. Mol. Biol. Cell 18: 4691-4697. (Pubitemid 350246672)
10. Häcker, H., and M. Karin. 2006. Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006: re13.
11. Semenza, G. L. 2011. Oxygen sensing, homeostasis, and disease. N. Engl. J. Med. 365: 537-547.
12. Colgan, S. P., and C. T. Taylor. 2010. Hypoxia: an alarm signal during intestinal inflammation. Nat Rev Gastroenterol Hepatol 7: 281-287.
13. Grenz, A., E. Clambey, and H. K. Eltzschig. 2012. Hypoxia signaling during intestinal ischemia and inflammation. Curr. Opin. Crit. Care 18: 178-185.
14. Kumar, S., Y. Yoshida, and M. Noda. 1993. Cloning of a cDNA which encodes a novel ubiquitin-like protein. Biochem. Biophys. Res. Commun. 195: 393-399. (Pubitemid 23266543)
15. Wada, H., K. Kito, L. S. Caskey, E. T. Yeh, and T. Kamitani. 1998. Cleavage of the C-terminus of NEDD8 by UCH-L3. Biochem. Biophys. Res. Commun. 251: 688-692. (Pubitemid 28512771)
16. Huang, D. T., D. W. Miller, R. Mathew, R. Cassell, J. M. Holton, M. F. Roussel, and B. A. Schulman. 2004. A unique E1-E2 interaction required for optimal conjugation of the ubiquitin-like protein NEDD8. Nat. Struct. Mol. Biol. 11: 927-935. (Pubitemid 39315295)
17. Mendoza, H. M., L. N. Shen, C. Botting, A. Lewis, J. Chen, B. Ink, and R. T. Hay. 2003. NEDP1, a highly conserved cysteine protease that deNEDDylates Cullins. J. Biol. Chem. 278: 25637-25643. (Pubitemid 36835317)
18. Liakopoulos, D., G. Doenges, K. Matuschewski, and S. Jentsch. 1998. A novel protein modification pathway related to the ubiquitin system. EMBO J. 17: 2208-2214. (Pubitemid 28171906)
19. Jones, J., K. Wu, Y. Yang, C. Guerrero, N. Nillegoda, Z. Q. Pan, and L. Huang. 2008. A targeted proteomic analysis of the ubiquitin-like modifier nedd8 and associated proteins. J. Proteome Res. 7: 1274-1287.
20. Parry, G., and M. Estelle. 2004. Regulation of cullin-based ubiquitin ligases by the Nedd8/RUB ubiquitin-like proteins. Semin. Cell Dev. Biol. 15: 221-229. (Pubitemid 38251651)
21. β-TrCP-mediated ubiquitination and processing of the NF-κB precursor p105. J. Biol. Chem. 277: 23253-23259.
22. Semenza, G. L. 2010. Oxygen homeostasis. Wiley Interdiscip. Rev. Syst. Biol. Med. 2: 336-361.
23. Sufan, R. I., and M. Ohh. 2006. Role of the NEDD8 modification of Cul2 in the sequential activation of ECV complex. Neoplasia 8: 956-963. (Pubitemid 44706246)
24. Giatromanolaki, A., E. Sivridis, E. Maltezos, D. Papazoglou, C. Simopoulos, K. C. Gatter, A. L. Harris, and M. I. Koukourakis. 2003. Hypoxia inducible factor 1α and 2α overexpression in inflammatory bowel disease. J. Clin. Pathol. 56: 209-213. (Pubitemid 36308037)
25. Mariani, F., P. Sena, L. Marzona, M. Riccio, R. Fano, P. Manni, C. D. Gregorio, A. Pezzi, M. P. Leon, S. Monni, et al. 2009. Cyclooxygenase-2 and hypoxia-inducible factor-1α protein expression is related to inflammation, and up-regulated since the early steps of colorectal carcinogenesis. Cancer Lett. 279: 221-229.
26. Khoury, J., J. C. Ibla, A. S. Neish, and S. P. Colgan. 2007. Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation. J. Clin. Invest. 117: 703-711. (Pubitemid 46348528)
27. Wu, K., K. Yamoah, G. Dolios, T. Gan-Erdene, P. Tan, A. Chen, C. G. Lee, N. Wei, K. D. Wilkinson, R. Wang, and Z. Q. Pan. 2003. DEN1 is a dual function protease capable of processing the C terminus of Nedd8 and deconjugating hyper-neddylated CUL1. J. Biol. Chem. 278: 28882-28891. (Pubitemid 36935799)
28. Cope, G. A., and R. J. Deshaies. 2003. COP9 signalosome: a multifunctional regulator of SCF and other cullin-based ubiquitin ligases. Cell 114: 663-671. (Pubitemid 37186763)
29. Lyapina, S., G. Cope, A. Shevchenko, G. Serino, T. Tsuge, C. Zhou, D. A. Wolf, N. Wei, A. Shevchenko, and R. J. Deshaies. 2001. Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome. Science 292: 1382-1385. (Pubitemid 32476226)
30. Soucy, T. A., P. G. Smith, M. A. Milhollen, A. J. Berger, J. M. Gavin, S. Adhikari, J. E. Brownell, K. E. Burke, D. P. Cardin, S. Critchley, et al. 2009. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature 458: 732-736.
31. Milhollen, M. A., T. Traore, J. Adams-Duffy, M. P. Thomas, A. J. Berger, L. Dang, L. R. Dick, J. J. Garnsey, E. Koenig, S. P. Langston, et al. 2010. MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB-dependent lymphoma. Blood 116: 1515-1523.
32. Ades, E. W., F. J. Candal, R. A. Swerlick, V. G. George, S. Summers, D. C. Bosse, and T. J. Lawley. 1992. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J. Invest. Dermatol. 99: 683-690. (Pubitemid 23002027)
33. Gao, F., J. Cheng, T. Shi, and E. T. Yeh. 2006. Neddylation of a breast cancer-associated protein recruits a class III histone deacetylase that represses NFκkappaB-dependent transcription. Nat. Cell Biol. 8: 1171-1177.
34. Sheta, E. A., H. Trout, J. J. Gildea, M. A. Harding, and D. Theodorescu. 2001. Cell density mediated pericellular hypoxia leads to induction of HIF-1α via nitric oxide and Ras/MAP kinase mediated signaling pathways. Oncogene 20: 7624-7634. (Pubitemid 33111862)
35. Lennon, P. F., C. T. Taylor, G. L. Stahl, and S. P. Colgan. 1998. Neutrophil-derived 5α-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation. J. Exp. Med. 188: 1433-1443. (Pubitemid 28489580)
36. Kumar, A., H. Wu, L. S. Collier-Hyams, Y. M. Kwon, J. M. Hanson, and A. S. Neish. 2009. The bacterial fermentation product butyrate influences epithelial signaling via reactive oxygen species-mediated changes in cullin-1 neddylation. J. Immunol. 182: 538-546.
37. Kumar, A., H.Wu, L. S. Collier-Hyams, J.M. Hansen, T. Li, K. Yamoah, Z. Q. Pan, D. P. Jones, and A. S. Neish. 2007. Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species. EMBO J. 26: 4457-4466. (Pubitemid 350036625)
38. Boh, B. K., P. G. Smith, and T. Hagen. 2012. 2011. Neddylation-induced conformational control regulates cullin RING ligase activity in vivo. J. Mol. Biol. 409: 136-145.
39. Liakopoulos, D., T. Büsgen, A. Brychzy, S. Jentsch, and A. Pause. 1999. Conjugation of the ubiquitin-like protein NEDD8 to cullin-2 is linked to von Hippel-Lindau tumor suppressor function. Proc. Natl. Acad. Sci. USA 96: 5510-5515. (Pubitemid 29234648)
40. Brooks, A. C., N. Menzies-Gow, S. R. Bailey, F. M. Cunningham, and J. Elliott. 2010. Endotoxin-induced HIF-1α stabilisation in equine endothelial cells: synergistic action with hypoxia. Inflamm. Res. 59: 689-698.
41. Kuschel, A., P. Simon, and S. Tug. 2012. Functional regulation of HIF-1α under normoxia: is there more than post-translational regulation? J. Cell. Physiol. 227: 514-524.
42. Tateishi, K., M. Omata, K. Tanaka, and T. Chiba. 2001. The NEDD8 system is essential for cell cycle progression and morphogenetic pathway in mice. J. Cell Biol. 155: 571-579. (Pubitemid 34289315)
43. Ehrentraut, S. F., and S. P. Colgan. 2012. Implications of protein post-translational modifications in IBD. Inflamm. Bowel Dis. 18: 1378-1388.
44. Guardavaccaro, D., and M. Pagano. 2004. Oncogenic aberrations of cullin-dependent ubiquitin ligases. Oncogene 23: 2037-2049. (Pubitemid 38496733)
45. Merlet, J., J. Burger, J. E. Gomes, and L. Pintard. 2009. Regulation of cullin-RING E3 ubiquitin-ligases by neddylation and dimerization. Cell. Mol. Life Sci. 66: 1924-1938.
46. MacManus, C. F., E. L. Campbell, S. Keely, A. Burgess, D. J. Kominsky, and S. P. Colgan. 2011. Anti-inflammatory actions of adrenomedullin through fine tuning of HIF stabilization. FASEB J. 25: 1856-1864.
47. Mikus, P., and W. Zundel. 2005. COPing with hypoxia. Semin. Cell Dev. Biol. 16: 462-473. (Pubitemid 41247870)
48. Sitkovsky, M., and D. Lukashev. 2005. Regulation of immune cells by local-tissue oxygen tension: HIF1a and adenosine receptors. Nat. Rev. Immunol. 5: 712-721. (Pubitemid 43086172)
49. Synnestvedt, K., G. T. Furuta, K. M. Comerford, N. Louis, J. Karhausen, H. K. Eltzschig, K. R. Hansen, L. F. Thompson, and S. P. Colgan. 2002. Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110: 993-1002.
50. Grenz, A., H. Zhang, T. Eckle, M. Mittelbronn, M. Wehrmann, C. Köhle, D. Kloor, L. F. Thompson, H. Osswald, and H. K. Eltzschig. 2007. Protective role of ecto-5′-nucleotidase (CD73) in renal ischemia. J. Am. Soc. Nephrol. 18: 833-845. (Pubitemid 46434500)
51. Song, Y. R., S. J. You, Y. M. Lee, H. J. Chin, D. W. Chae, Y. K. Oh, K. W. Joo, J. S. Han, and K. Y. Na. 2010. Activation of hypoxia-inducible factor attenuates renal injury in rat remnant kidney. Nephrol. Dial. Transplant. 25: 77-85.
52. Theilig, F., A. K. Enke, B. Scolari, D. Polzin, S. Bachmann, and R. Koesters. 2011. Tubular deficiency of von Hippel-Lindau attenuates renal disease progression in anti-GBM glomerulonephritis. Am. J. Pathol. 179: 2177-2188.
53. Remick, D. G., G. R. Bolgos, J. Siddiqui, J. Shin, and J. A. Nemzek. 2002. Six at six: interleukin-6 measured 6 h after the initiation of sepsis predicts mortality over 3 days. Shock 17: 463-467.
54. Cernada, M., N. Badía, V. Modesto, R. Alonso, A. Mejías, S. Golombek, and M. Vento. 2012. Cord blood interleukin-6 as a predictor of early-onset neonatal sepsis. Acta Paediatr. 101: e203-e207.